|
1
|
Ali NJ, Sillis M, Andrews BE, Jenkins PF
and Harrison BD: The clinical spectrum and diagnosis of Mycoplasma
pneumoniae infection. Q J Med. 58:241–251. 1986.PubMed/NCBI
|
|
2
|
Bradley JS and Jackson MA: Committee on
Infectious Diseases; American Academy of Pediatrics: The use of
systemic and topical fluoroquinolones. Pediatrics. 128:e1034–e1045.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Pereyre S, Goret J and Bébéar C:
Mycoplasma pneumoniae: Current knowledge on macrolide resistance
and treatment. Front Microbiol. 7:9742016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wu PS, Chang LY, Lin HC, Chi H, Hsieh YC,
Huang YC, Liu CC, Huang YC and Huang LM: Epidemiology and clinical
manifestations of children with macrolide-resistant Mycoplasma
pneumoniae pneumonia in Taiwan. Pediatr Pulmonol. 48:904–911. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wu HM, Wong KS, Huang YC, Lai SH, Tsao KC,
Lin YJ and Lin TY: Macrolide-resistant Mycoplasma pneumoniae in
children in Taiwan. J Infect Chemother. 19:782–786. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sillis M: The limitations of IgM assays in
the serological diagnosis of Mycoplasma pneumoniae infections. J
Med Microbiol. 33:253–258. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Thacker WL and Talkington DF: Analysis of
complement fixation and commercial enzyme immunoassays for
detection of antibodies to Mycoplasma pneumoniae in human serum.
Clin Diagn Lab Immunol. 7:778–780. 2000.PubMed/NCBI
|
|
8
|
Granström M, Holme T, Sjögren AM, Ortqvist
A and Kalin M: The role of IgA determination by ELISA in the early
serodiagnosis of Mycoplasma pneumoniae infection, in relation to
IgG and mu-capture IgM methods. J Med Microbiol. 40:288–292. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yamazaki T, Narita M, Sasaki N, Kenri T,
Arakawa Y and Sasaki T: Comparison of PCR for sputum samples
obtained by induced cough and serological tests for diagnosis of
Mycoplasma pneumoniae infection in children. Clin Vaccine Immunol.
13:708–710. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lieberman D, Lieberman D, Ben-Yaakov M,
Shmarkov O, Gelfer Y, Varshavsky R, Ohana B, Lazarovich Z and
Boldur I: Serological evidence of Mycoplasma pneumoniae infection
in acute exacerbation of COPD. Diagn Microbiol Infect Dis. 44:1–6.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lieberman D, Lieberman D, Korsonsky I,
Ben-Yaakov M, Lazarovich Z, Friedman MG, Dvoskin B, Leinonen M,
Ohana B and Boldur I: A comparative study of the etiology of adult
upper and lower respiratory tract infections in the community.
Diagn Microbiol Infect Dis. 42:21–28. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Watkins-Riedel T, Stanek G and Daxboeck F:
Comparison of SeroMP IgA with four other commercial assays for
serodiagnosis of Mycoplasma pneumoniae pneumonia. Diagn Microbiol
Infect Dis. 40:21–25. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chang HY, Chang LY, Shao PL, Lee PI, Chen
JM, Lee CY, Lu CY and Huang LM: Comparison of real-time polymerase
chain reaction and serological tests for the confirmation of
Mycoplasma pneumoniae infection in children with clinical diagnosis
of atypical pneumonia. J Microbiol Immunol Infect. 47:137–144.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Medjo B, Atanaskovic-Markovic M, Radic S,
Nikolic D, Lukac M and Djukic S: Mycoplasma pneumoniae as a
causative agent of community-acquired pneumonia in children:
Clinical features and laboratory diagnosis. Ital J Pediatr.
40:1042014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ma YJ, Wang SM, Cho YH, Shen CF, Liu CC,
Chi H, Huang YC, Huang LM, Huang YC, Lin HC, et al: Taiwan
Pediatric Infectious Disease Alliance: Clinical and epidemiological
characteristics in children with community-acquired mycoplasma
pneumonia in Taiwan: A nationwide surveillance. J Microbiol Immunol
Infect. 48:632–638. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Gavranich JB and Chang AB: Antibiotics for
community acquired lower respiratory tract infections (LRTI)
secondary to Mycoplasma pneumoniae in children. Cochrane Database
Syst Rev. 3:CD0048752005.
|
